Actorius Innovations and Research

Actorius Innovations and Research is an Indian biotechnology company focused on developing high-sensitivity diagnostic tools for oncology. The company's core technology, OncoDiscover, is a liquid biopsy platform that utilizes immunomagnetic nanotechnology to detect and enumerate Circulating Tumor Cells (CTCs) from blood samples. As the first Indian company to receive DCGI approval for a CTC-based diagnostic test, Actorius provides clinicians with a minimally invasive method to monitor cancer progression and treatment response. Their clinical focus includes breast, prostate, colorectal, and head and neck cancers, aiming to integrate personalized medicine into routine oncology care. The company operates out of Pune and collaborates with leading healthcare providers to improve patient outcomes through early detection.